Increasing Flexibility in Vaccine Manufacturing Processes and Facilities with Single-Use Disposable Technologies
Posted on July 9, 2020
Tony D’Amore, Vice President, Bioprocess R&D
Yan-ping Yang, Director of Downstream Processing, Bioprocess R&D
Sanofi Pastuer
Abstract The vaccine industry is anticipated to experience significant market growth over the next decade, primarily to occur in Asian and other emerging markets. The vaccine industry is high risk with long cycle times, requiring approximately 12 years to bring a product from pre-clinical to licens...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















